Ensuring Community Access to Pharmacist Services Act

If passed, Medicare spending increases by an unknown amount beginning 2026 (no CBO score provided). Community pharmacies gain a new revenue stream and competitive advantage in capturing acute care visits. Physician practices may see volume losses for minor acute illness visits, particularly in areas with dense pharmacy networks. Beneficiary access to point-of-care testing for respiratory infections improves but with 20% out-of-pocket coinsurance. State-level precedents: several states (California, Colorado, Louisiana, Texas) have expanded pharmacist scope of practice for testing and immunizations; outcomes show increased vaccination rates and convenience but mixed evidence on cost-effectiveness and quality parity with physician-delivered care. The bill's restriction to specified conditions and requirement for physician collaboration/supervision narrows scope compared to broader state-level expansions.